The Medical University of South Carolina is Launching a Psychedelic Research Center
Scheduled to open in 2021, the new center will study the therapeutic potential of MDMA, psilocybin, DMT, and mescaline.
Articles
Eleusis’s Phase I Alzheimer’s Trial Finds Favorable Safety & Tolerability of LSD in Older Volunteers
There were no abnormalities or deviations in safety or cognitive outcome measures compared to the baseline data.
What is Kratom?
It is a plant that contains over 40 alkaloid and non-alkaloid compounds, some of which have analgesic and psychoactive properties.
Single Ketamine Dose Could Help to Treat Problematic Drinking Behavior
New research suggests that ketamine can aid in reorganizing alcohol-related memories.
Scientists Test the Effects of Inhaling Synthetic 5-MeO-DMT
Some changes occured to biomarkers for stress and inflammation. The subjective effects reveal more evidence of the entourage effect.
COMPASS Patent Highlights Importance of Crystallography in Psychedelic Drug Development
The scope and validity of this patent will depend on how x-ray diffraction data is interpreted.
Placebo-Controlled Study Finds Psilocybin Formulation is Safe and Well-Tolerated in Healthy Volunteers
The study used an investigational psilocybin formulation called COMP360 developed and produced by COMPASS Pathways.
Study Identifies Compounds and Mechanism that Causes Psilocybin Mushroom Bluing
These bluing compounds can exist as dimeric, trimeric, and tetrameric forms of psilocin and/or its structural analogs.
Altered Oscillations: The Modulatory Effect of DMT on Brain Waves
A recent Nature paper provides novel insights into the neural correlates of the Breakthrough Experience associated with DMT.
Study Finds ALD-52, 1P-LSD, and 1B-LSD Are Prodrugs of LSD
Identifying and understanding prodrugs is an essential component of psychedelic drug research.